Unknown

Dataset Information

0

A fully 3D-printed versatile tumor-on-a-chip allows multi-drug screening and correlation with clinical outcomes for personalized medicine.


ABSTRACT: Optimal clinical outcomes in cancer treatments could be achieved through the development of reliable, precise ex vivo tumor models that function as drug screening platforms for patient-targeted therapies. Microfluidic tumor-on-chip technology is emerging as a preferred tool since it enables the complex set-ups and recapitulation of the physiologically relevant physical microenvironment of tumors. In order to overcome the common hindrances encountered while using this technology, a fully 3D-printed device was developed that sustains patient-derived multicellular spheroids long enough to conduct multiple drug screening tests. This tool is both cost effective and possesses four necessary characteristics of effective microfluidic devices: transparency, biocompatibility, versatility, and sample accessibility. Compelling correlations which demonstrate a clinical proof of concept were found after testing and comparing different chemotherapies on tumor spheroids, derived from ten patients, to their clinical outcomes. This platform offers a potential solution for personalized medicine by functioning as a predictive drug-performance tool.

SUBMITTER: Steinberg E 

PROVIDER: S-EPMC10643569 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

A fully 3D-printed versatile tumor-on-a-chip allows multi-drug screening and correlation with clinical outcomes for personalized medicine.

Steinberg Eliana E   Friedman Roy R   Goldstein Yoel Y   Friedman Nethanel N   Beharier Ofer O   Demma Jonathan Abraham JA   Zamir Gideon G   Hubert Ayala A   Benny Ofra O  

Communications biology 20231113 1


Optimal clinical outcomes in cancer treatments could be achieved through the development of reliable, precise ex vivo tumor models that function as drug screening platforms for patient-targeted therapies. Microfluidic tumor-on-chip technology is emerging as a preferred tool since it enables the complex set-ups and recapitulation of the physiologically relevant physical microenvironment of tumors. In order to overcome the common hindrances encountered while using this technology, a fully 3D-print  ...[more]

Similar Datasets

| S-EPMC5811381 | biostudies-literature
| S-EPMC4829438 | biostudies-literature
| S-EPMC9269401 | biostudies-literature
| S-EPMC10642728 | biostudies-literature
| S-EPMC8703879 | biostudies-literature
| S-EPMC8234073 | biostudies-literature
| S-EPMC4822857 | biostudies-literature
| S-EPMC9322562 | biostudies-literature
| S-EPMC8442928 | biostudies-literature
| S-EPMC6157116 | biostudies-literature